1Klaassen CD,Adamson RH,Andrews GK,et al.National cancer institute workshop on the possible roles of metallothionein in carcinogenesis[].Cancer Research.1993
2Abdel-Mageed AB,Agrawal KC.Activation of nuclear factor kB: potential role in metallothionein-mediated mitogenic response[].Cancer Research.1998
3Kagi JHR,Schaffer A.Biochemistry of metallothionein[].Biochemistry.1988
3Rossman TG, Goncharova El. Spontaneous mutagenesis in mam-malian cells is caused mainly by oxidative events and can be blocked by antioxidants and metallothionein[ J]. Mutat Res, 1998 ;402(1-2) :103-10.
5Trock BJ, Ceonessa F, Clarke R, et aL Muhidrug resistance in breast cancer:a Meta-analysis of MDRI /gp-170 expression and it possible functional significance[J]. J Natl Cancer Inst,1997 ;89(13) :917-31.
6Cherian MG, Jayasurya A, Bay BH. Metallothionein in human tumors and potential roles in carcinogenesis [ J ]. Mutat Res, 2003,533 (1/2) :201 -209.
7Moussa M, Kloth D,Peers G,et al. Metallothionein expression in prostatic carcinoma correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen[J]. Clin Invest Med, 1997,20(6):371 -380.
8Saga Y, Hashimoto H, Yachiku S, et al. lmmunohistochemical expression of metallothionein in human bladder cancer:correlation with histopathological parameters and patient survival [ J ]. J Urol,2002, 168(5):2227 -2231.
9Hasumi M, Suzuki K, Matsui H, et al. Regulation of metallothiouein and zinc transporter expression in human prostate cancer cells and tissues [ J ]. Cancer Lett,2003, 200 (2) : 187 - 195.
10Smith DJ,Jaggi M,Zhang W,et al. Metallothioneins and resistance to cisplatin and radiation in prostate cancers[ J ]. Urology,2006, 67(6) : 1341 -1347.
